I am a
Home I AM A Search Login

Papers of the Week


2022 May 08


Clin Neurol Neurosurg


218

Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine.

Authors

Hernández A G
Clin Neurol Neurosurg. 2022 May 08; 218:107282.
PMID: 35598579.

Abstract

The aim of this study was to determine the efficacy and tolerability of treatment with a Palmitoylethanolamide (PEA)-based nutraceutical in patients with episodic migraine.